May 26, 2026
In the News
March 10, 2026
Biotech2050 Podcast: Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
January 27, 2026
Base to Base Biotech Podcast: Natural Killer Cell Therapy
November 1, 2025
SDBJ: Artiva Bio Soaring on Focus Shift from Oncology to Autoimmune Disease
June 2, 2025
Inside Precision Medicine: Asked & Answered with Artiva’s CMO Dr. Subhashis Banerjee
April 28, 2025
Pharmaceutical Manufacturer Q&A: Artiva Allogeneic NK Cell Therapies for Treating Autoimmune Disease
April 10, 2025
GEN: The Body’s Delta Force: Natural Killer Cells Re-Emerge
March 5, 2025
The Bio Report Podcast: Turning Natural Killers into Off-the-Shelf Therapies for Autoimmune Disease
February 6, 2025
In Vivo: Artiva Leverages Unmodified NK Cells To Challenge CAR-T Paradigm
January 28, 2025